Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Perceptions about the standards of medical graduates in Pakistan: A brief literature review.

JPMA. The Journal of the Pakistan Medical Association·2020

Same author

Assessing team in team objectively structured bedside assessment (TOSBA).

JPMA. The Journal of the Pakistan Medical Association·2020

Same author

Peer assessment of professional behaviour: A proposed model for medical schools in Pakistan.

JPMA. The Journal of the Pakistan Medical Association·2018

Same author

Therapeutic bronchoalveolar lavage with conventional treatment in allergic bronchopulmonary aspergillosis.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2015

Same author

Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2015

Same author

Comparison of sensitivity of QuantiFERON-TB gold test and tuberculin skin test in active pulmonary tuberculosis.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2013

Search research articles

Related Experiment Videos

Post-tuberculous chronic obstructive pulmonary disease.

Inam Muhammad Baig¹, Waseem Saeed, Kanwal Fatima Khalil

¹Department of Medicine, Combined Military Hospital, Multan Cantt. inammbaig@yahoo.com

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

|August 7, 2010

Summary

Chronic obstructive pulmonary disease (COPD) frequently develops after treated pulmonary tuberculosis. Obstructive ventilatory defects are the most common lung function abnormality found in these patients.

Related Experiment Videos

Area of Science:

Pulmonology
Infectious Disease Epidemiology
Respiratory Medicine

Background:

Pulmonary tuberculosis (TB) is a significant global health issue.
Long-term sequelae of treated TB are not fully understood.
Chronic obstructive pulmonary disease (COPD) is a potential complication.

Purpose of the Study:

To investigate the incidence of COPD following treatment for pulmonary TB.
To characterize the pulmonary function abnormalities in patients with a history of TB.

Main Methods:

A case series design was employed.
Forty-seven adult patients previously treated for pulmonary TB were included.
Pulmonary function tests (spirometry) were conducted to assess FVC, FEV1, and FEV1/FVC ratios.

Main Results:

Over half (55.3%) of the patients exhibited an obstructive ventilatory defect.
The majority of obstructive defects were severe (69.2%) or moderate (23.0%).
Restrictive (29.7%) and mixed (14.8%) patterns were also observed.

Conclusions:

COPD can be a chronic complication of pulmonary tuberculosis.
Obstructive ventilatory defects are a common pulmonary function derangement post-TB treatment.
Further research into TB-related lung damage is warranted.